Fundraising FoxShantonpharma
1 known investors
Find your way into Shantonpharma
Sign up to see every warm intro you have to Shantonpharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Shantonpharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Shanton Pharma is a clinical-stage biotech company developing drugs for gout, hyperuricemia, and pruritus. It focuses on researching and commercializing therapies for these conditions to serve patients and medical communities.
Investors · 1
3E Bioventures Capitallisted by 3E Bioventures CapitalPalo Alto
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Shantonpharma do?
- Shanton Pharma is a clinical-stage biotech company developing drugs for gout, hyperuricemia, and pruritus. It focuses on researching and commercializing therapies for these conditions to serve patients and medical communities.
- Who are Shantonpharma's investors?
- Shantonpharma's investors include 3E Bioventures Capital.